A practical framework to approach the development and evaluation of patient registries for rare diseases
Maya S Vaishnaw, Rachel Richesson

TL;DR
This paper provides a framework to help rare disease communities decide when and how to create patient registries, based on their research needs and goals.
Contribution
The paper introduces a unified framework for classifying rare disease registries based on research questions and scientific needs.
Findings
The framework helps stakeholders prioritize registry objectives and design.
It supports decision-making about initiating and funding registries.
The framework is based on synthesizing existing classifications and registry experiences.
Abstract
Patient registries are essential to rare disease research, but the implementation and maintenance of a registry requires substantial investments. Despite the large number of rare disease communities that currently have, or are planning for, a registry, there is little guidance on if and when a rare disease registry should be established. There is also little guidance on how to articulate registry objectives to address current and evolving scientific and community needs. A practical framework is needed to assist rare disease registry stakeholders to understand and prioritize registry objectives and requirements for registry design, data collection, and funding. In this review, we synthesize existing patient registry classifications and prior reports of rare disease registry experience into a unified framework characterizing rare disease registries by their types of research questions…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenomics and Rare Diseases · Health Systems, Economic Evaluations, Quality of Life · Cystic Fibrosis Research Advances
